Overview

• The transaction covers ieso’s NHS-facing UK telecare services, with contracts across roughly one third of England’s integrated care systems and a national agreement in Scotland set to continue under Mindler.
• The combined platform will provide live video therapy alongside typed cognitive behavioural therapy supported by AI-driven clinical tools to help widen access and manage waiting times.
• Patient data will continue to be handled by ieso Digital Health UK in line with NHS requirements to maintain service continuity during integration.
• Managing director Dr Charlotte Housden will remain in post to oversee the transition and the scaling of services under the Mindler brand.
• Financial terms were not disclosed, though Tech Funding News estimated a £15–25 million valuation based on revenue multiples, while the ieso parent refocuses on its Velora clinical AI platform.